Evaluations of extracellular PH within in vivo tumors using acidocest MRI

Magnetic Resonance in Medicine

Volumn 72, Issue 5, 2014, Pages 1408-1417

  Chen, Liu Qi ^a   Howison, Christine M ^b   Jeffery, Justin J ^c   Robey, Ian F ^c,d   Kuo, Phillip H ^c,d   Pagel, Mark D ^a,b,c,d  

^a University of Arizona   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bicarbonate treatment; CEST MRI; CEST FISP; Iopromide; Tumor pH

Indexed keywords

AMIDES; COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; NONINVASIVE MEDICAL PROCEDURES;

BICARBONATE TREATMENT; CEST MRIS; CEST-FISP; IOPROMIDE; TUMOR PH;

TUMORS;

BICARBONATE; CONTRAST MEDIUM; IOPROMIDE; IOHEXOL;

ALKALINIZATION; ANIMAL EXPERIMENT; ARTICLE; BLADDER; BREAST CARCINOMA; DRUG UPTAKE; IN VIVO STUDY; KIDNEY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PH; ACIDOSIS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; EXPERIMENTAL MAMMARY NEOPLASM; PROCEDURES;

ACIDOSIS; ANIMALS; BICARBONATES; CONTRAST MEDIA; HYDROGEN-ION CONCENTRATION; IOHEXOL; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; X-RAY MICROTOMOGRAPHY;

EID: 84907957267     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25053     Document Type: Article

References (47)

1. Warburg O. On metabolism of tumours. London, UK: Constable; 1930.
2. Gillies RJ, Gatenby RA. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 2007;26:311-317.
3. Raghunand N, Gatenby RA, Gillies RJ. Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 2003; 76:S11-S22.
4. Gatenby RA, Gawlinski ET, Gmitro, AF, Kaylor B, Gillies RJ. Acidmediated tumor invasion: A multidisciplinary study. Cancer Res 2006;66:5216-5223.
5. Estrella V, Chen T, Lloyd M, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 2013;73:1524- 1535.
6. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-899.
7. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006;4:61-70.
8. Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008;8:56-61.
9. Arcamone F, Franceschi G, Penco S, Selvia A. Adriamycin 14- hydroxydaunomycin: A novel antitumor antibiotic. Tetrahedron Lett 1969;13:1007-1016.
10. Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist Updates 2002;3:39-47.
11. Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol 2003;66: 1207-1218.
12. Raghunand N, Mahoney BP, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 2003;66:1219- 1229.
13. Fais S, De Milito A, You H, Qin W. Targeting vacuolar H- ATPases as a new strategy against cancer. Cancer Res 2007;67: 10627-10630.
14. De Milito A, Canese R, Marino ML, et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010;127: 207-219.
15. Robey IF, Baggett BK, Kirkpatrick ND, et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009;69: 2260-2268.
16. Martin NK, Gaffney EA, Gatenby RA, Gillies RJ, Robey IF, Maini PK. A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system. Math Biosci 2011; 230:1-11.
17. Silva AS, Yunes JA, Gillies RJ, Gatenby RA. The potential role of systemic buffers in reducing intratumoral extracellular pH and acidmediated invasion. Cancer Res 2009;69:2677-2684.
18. Mordon S, Devoisselle JM, Maunoury V. In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5, 6-carboxyfluorescein): Instrumental and experimental studies. Photochem Photobiol 1994;60:274-279.
19. Martin GR, Jain RK. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 1994;54:5670-5674.
20. Kearfott KJ, Junck L, Rottenberg DA. C-11 dimethyloxazolidinedione (DMO): biodistribution, radiation absorbed dose, and potential for PET measurement of regional brain pH: concise communication. J Nuc Med 1983;24:805-811.
21. Vavere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res 2009;69:4510-4516.
22. Khramtsov VV, Grigorev IA, Foster MA, Lurie DJ, Nicholson I. Biological applications of spin pH probes. Cell Mol Biol 2000;46:1361-1374.
23. Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 2005;7:287-326.
24. Gallagher FA, Kettunen MI, Day SE, et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008;453:940-943.
25. Yoo B, Pagel MD. An overview of responsive MRI contrast agents for molecular imaging. Front Biosci 2008;13:1733-1752.
26. Martinez GV, Zhang X, Garcia-Martin ML, Morse DL, Woods M, Sherry AD, Gillies RJ. Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed 2011;24:1380-1391.
27. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000;44:799-802.
28. Liu G, Ali MM, Yoo B, Griswold MA, Tkach JA, Pagel MD. PARACEST MRI with improved temporal resolution. Magn Reson Med 2009; 61:399-408.
29. Grad J, Bryant RG. Nuclear magnetic cross-relaxation spectroscopy. J Magn Reson 1990;90:1-8.
30. Liu G, Li Y, Sheth VR, Pagel MD. Imaging in vivo extracellular pH with a single PARACEST MRI contrast agent. Mol Imaging 2012;11: 47-57.
31. Sheth VR, Li Y, Chen LQ, Howison CM, Flask CA, Pagel MD. Measuring in vivo tumor pHe with CEST-FISP MRI. Measuring in vivo tumor pHe with CEST-FISP MRI. Magn Reson Med 2012;67: 760-768.
32. Longo DL, Dastru W, Digilio G, et al. Iopamidol as a responsive MRIchemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T. Magn Reson Med 2010;65: 202-211.
33. Shah T, Lu L, Dell KM, Pagel MD, Griswold MA, Flask CA. CESTFISP: A novel technique for rapid chemical exchange saturation transfer MRI at 7 T. Magn Reson Med 2011;65:432-437.
34. Sheth VR, Liu G, Li Y, Pagel MD. Improved pH measurements with a single PARACEST MRI contrast agent. Contrast Media Mol Imaging 2012;7:26-34.
35. Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with Image J. Biophoton Int 2004;11:36-42.
36. Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 2008;3:136-149.
37. Ali MM, Liu G, Shah T, Flask CA, Pagel MD. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res 2009;42:915- 924.
38. Woessner DE, Zhang S, Merritt ME, Sherry AD. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn Reson Med 2005;53: 790-799.
39. Randtke EA, Chen LQ, Corrales LR, Pagel MD. The Hanes-Woolf linear QUESP method improves the measurements of fast chemical exchange rates with CEST MRI. Magn Reson Med 2014;71:1603- 1612.
40. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic resonance imaging: Physical principles and sequence design. New York, NY: Wiley-Liss; 1999.
41. Pagel MD. The hope and hype of multimodality imaging contrast agents. Nanomedicine (Lond) 2011;6:945-948.
42. Dixon WT, Hancu I, Ratnakar SJ, Sherry AD, Lenkinski RE, Alsop DC. A multislice gradient echo pulse sequence for CEST imaging. Magn Reson Med 2010;63:253-256.
43. Martin NK, Robey IF, Gaffney EA, Gillies RJ, Gatenby RA, Maini PK. Predicting the safety and efficacy of buffer therapy to raise tumour pHe: An integrative modelling study. Br J Cancer 2012;106:1280- 1287.
44. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Silver Spring, MD: U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER); published July 2005.
45. Liu XD, Chen I. Prediction of drug clearance in humans from laboratory animals based on body surface area. Eur J Drug Metab Pharmacokinet 2001;26:249-256.
46. Sun PZ, Benner T, Kumar A, Sorensen AG. Investigation of optimizing and translating pH-sensitive pulsed-chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner. Magn Reson Med 2008;60:834-841.
47. Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl, PC. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 2008;60:842-849.